glp-1 gip medications long term effects Potential metabolic and mechanism of GI side effects of Weight loss medicine is changing

Modulating mitochondrial bioenergetics may be an effective treatment for HF since empagliflozin treatment significantly increased the myocardial ATP levels, myocardial mitochondrial complex I activity, and myocardial mitochondrial respiratory control ratio at 6 and 24 h after return of spontaneous circulation (ROSC) [119]

To wrap up an eventful year of GLP-1 research, here are Omada Insights Labs top takeaways of 2025, and what they mean for the future of cardiometabolic care

Heres How

These two incretins cause slower movement of food from the stomach to the small intestine in a process known as gastroparesis

Muscle loss slows resting metabolism, increases the risk of weight regain after stopping, and in older patients, significantly impacts physical function and fall risk